Physician profile
Markquetta Jackson
NPI 1013358183
$6,432.04
in general payments reported to CMS, 2019-2025
14 companies · $577 in 2025
The $577 reported for 2025 was more than what a typical Psychiatric/Mental Health (Nurse Practitioner) provider received nationally (typical 2025 total: $257).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,769 · 2022: $1,971 · 2023: $1,461 · 2024: $653 · 2025: $577.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,643 · Education: $48.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,642.95 |
| Education | $48.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merz North America, INC. | $4,234.35 | 2021-2023 | |
| Abbvie INC. | $518.13 | 2023-2025 | |
| Abbott Laboratories | $283.56 | 2021-2024 | Proclaim |
| Bayer Healthcare Pharmaceuticals INC. | $231.69 | 2021-2023 | |
| Allergan, INC. | $189.57 | 2021-2022 | |
| Sanofi-Aventis U.S. LLC | $166.41 | 2024 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $152.37 | 2024 | Caplyta |
| Galderma Laboratories, L.P. | $137.40 | 2021-2023 | |
| Evoke Pharma, INC. | $124.99 | 2025 | |
| Teva Pharmaceuticals USA, INC. | $122.54 | 2023 | Austedo Xr |
| Axsome Therapeutics, INC. | $119.70 | 2025 | Auvelity |
| Corcept Therapeutics | $100.00 | 2024 | Korlym |
| Inspire Medical Systems, INC. | $39.26 | 2024 | Inspire |
| Novo Nordisk INC | $12.07 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Markquetta Jackson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.